Year-end Sale % OFF 
Abstract
Fluopsin C (FlpC) is an organocupric secondary metabolite with low-molecular-weight, produced by some Pseudomonas and Streptomyces bacteria. The compound was identified in 1970 as prismatic dark-green crystals, with strong antimicrobial activity against several human and phytopathogens. Due to its high cytotoxicity, research on this compound decreased after the 1970s. During the early 2000s, FlpC gained more attention as a promising compound by which to develop new antimicrobials to control human, animal, and plant pathogens. This study provides an overview of the results pertaining to the in vitro and in vivo antimicrobial activity of pure FlpC, as well as semi-purified fractions containing FlpC, against phytopathogenic microorganisms. Furthermore, the bioprospection history of the extensively researched FlpC-producing Pseudomonas aeruginosa LV strain and the related molecular evidence regarding the compound’s biosynthesis are discussed. Overall, FlpC is proposed to be an important alternative to antimicrobial resistance in human and animal health, and in tackling the negative environmental impacts caused by the exacerbated use of pesticides against phytopathogens.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
